Redmile Group’s SkinHealth Systems SKIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,109,564
Closed -$24.9M 72
2022
Q3
$24.9M Sell
2,109,564
-3,076,784
-59% -$38.9M 0.96% 34
2022
Q2
$66.7M Sell
5,186,348
-118,157
-2% -$1.58M 2.55% 9
2022
Q1
$89.5M Buy
5,304,505
+221,700
+4% +$3.66M 2.8% 10
2021
Q4
$123M Sell
5,082,805
-2,400,901
-32% -$61.9M 2.79% 10
2021
Q3
$194M Buy
7,483,706
+1,130,460
+18% +$24.9M 3.39% 7
2021
Q2
$107M Buy
6,353,246
+4,370,497
+220% +$59.8M 1.58% 19
2021
Q1
$21.4M Buy
1,982,749
+982,749
+98% +$10.8M 0.3% 69
2020
Q4
$11.3M Buy
+1,000,000
New +$10.8M 0.14% 72

Other funds holding SKIN

Redmile Group's SKIN Position: Q4 2022 in Review

Redmile Group sold out of SkinHealth Systems (SKIN) in Q4 2022, closing a stake of 2,109,564 shares — an estimated $24.9M sold.

Redmile Group first reported a position in SKIN in Q4 2020 and held it in 8 quarters. The position peaked at $194M in Q3 2021. 158 funds tracked by Wall St. Rank hold SKIN as of Q4 2022.

  • Redmile Group reported no remaining SkinHealth Systems position as of Q4 2022 after selling out during the quarter.
  • Redmile Group sold 2,109,564 SkinHealth Systems shares in Q4 2022, an estimated $24.9M.
  • Redmile Group first reported a position in SkinHealth Systems in Q4 2020 and held it in 8 quarters.
  • Redmile Group's SkinHealth Systems position peaked at $194M in Q3 2021.
  • 158 funds tracked by Wall St. Rank held SkinHealth Systems as of Q4 2022.

Based on Redmile Group's 13F filing for Q4 2022, filed 14 Feb 2023.